Pluripotent Stem Cells Research
Pluripotent Stem Cells Research is a research topic within Molecular Biology. Science Explorer counts 39k research works in it since 1950. 22.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the induction, differentiation, and reprogramming of pluripotent stem cells, including embryonic and induced pluripotent stem cells. It covers topics such as transcriptional regulatory circuitry, neural and cardiac differentiation, epigenetic memory, and the use of defined factors for reprogramming. The research also explores the potential applications of pluripotent stem cells in modeling development, disease, and tissue regeneration.
- Pluripotent Stem Cells
- Induced Pluripotent Stem Cells
- Embryonic Stem Cells
- Differentiation
- Reprogramming
- Transcriptional Regulation
- Neural Differentiation
- Cardiomyocytes
- Epigenetic Remodeling
- Cellular Reprogramming
- Research works
- 39k fractional, since 1950
- In the world top 10%
- 8.8k per year above
- Top-10% rate
- 22.8% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -7% the tick is no change
Which countries lead Pluripotent Stem Cells Research research?
By volume, the United States and China publish the most (1.4k and 951 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.4k works
- 2 China 951 works
- 3 Japan 420 works
- 4 Germany 259 works
- 5 United Kingdom 246 works
- 6 India 214 works
- 7 South Korea 197 works
- 8 France 152 works
- 9 Canada 147 works
- 10 Italy 143 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Pluripotent Stem Cells Research research?
By volume in 2022–2025, Kyoto University publishes the most Pluripotent Stem Cells Research research, followed by Harvard University and Stanford University.
By volume, 2022–2025
- 1 Kyoto UniversityJapan 43 works
- 2 Harvard UniversityUnited States 30 works
- 3 Stanford UniversityUnited States 28 works
- 4 The University of OsakaJapan 22 works
- 5 The University of TokyoJapan 21 works
- 6 Chinese Academy of SciencesChina 20 works
- 7 University of North Carolina at Chapel HillUnited States 20 works
- 8 InsermFrance 19 works
- 9 University of MichiganUnited States 18 works
- 10 Keio UniversityJapan 18 works
Who are the leading researchers in Pluripotent Stem Cells Research?
The most-cited researchers publishing on Pluripotent Stem Cells Research include Róbert Langer and Darwin J. Prockop.
- 1 Róbert Langer United States 4.2k citations
- 2 Darwin J. Prockop United States 3.8k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Pluripotent Stem Cells Research research done?
The largest centres of Pluripotent Stem Cells Research research in 2022–2025 are Beijing (China), Tokyo (Japan), Shanghai (China) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Kyoto, Leiden and Osaka.
Largest cities, 2022–2025
Where it is the local speciality
- KyotoJP · 54.9 works6.9×
- LeidenNL · 20.6 works5.8×
- OsakaJP · 43.4 works5.0×
- CambridgeGB · 42.2 works4.8×
Location quotient: how much more of its research is in Pluripotent Stem Cells Research than the world average.
Where is the best place to study Pluripotent Stem Cells Research?
Among universities, judged by research, Kyoto University, Harvard University and Stanford University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Kyoto UniversityJapan | 65.1 | 17.5% | 11.1× | 43 | +2.5% |
| 2 | Harvard UniversityUnited States | 57.0 | 30.5% | 4.5× | 30 | -32.1% |
| 3 | Stanford UniversityUnited States | 48.2 | 22.6% | 4.4× | 28 | -17.8% |
| 4 | University of CambridgeUnited Kingdom | 47.8 | 32.1% | 2.9× | 17 | -28.1% |
| 5 | Keio UniversityJapan | 47.7 | 16.3% | 9.4× | 18 | -38.8% |
| 6 | University of Chinese Academy of SciencesChina | 46.9 | 26.2% | 1.6× | 14 | +397.3% |
| 7 | Karolinska InstitutetSweden | 46.9 | 22.4% | 5.3× | 12 | -12.5% |
| 8 | The University of OsakaJapan | 46.2 | 15.9% | 6.6× | 22 | +13.2% |
| 9 | Washington University in St. LouisUnited States | 44.0 | 29.1% | 3.6× | 13 | +30.6% |
| 10 | University of MichiganUnited States | 43.3 | 30.7% | 2.5× | 18 | -14.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Pluripotent Stem Cells Research research growing?
Output in 2018–2022 was 7% lower than in 2013–2017, peaking in 2014. The fastest-growing topics are Pluripotent Stem Cells Research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.